Clinical Trial Update: An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients

View source ↗

Summary

An observational study evaluated the safety and effectiveness of repaglinide in Chinese patients with Type 2 diabetes mellitus. The study was sponsored by Novo …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Repaglinide (Repaglinide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED